AbbVie Inc. vs The Goldman Sachs Group, Inc.
AbbVie Inc. is worth $464.575B, 1.5× the $302.952B market cap of The Goldman Sachs Group, Inc.. Updated daily.
| Metric | AbbVie Inc.ABBV  | |
|---|---|---|
| Market cap | $464.575B | $302.952B |
| Global rank | #1 | #2 |
| Share price | $262.90 | $1,040.46 |
| Change | +5.12% | +0.58% |
| Revenue | $61.160B | $58.283B |
| Net income | $4.226B | $17.176B |
| Country | United States | United States |
| Sector | Healthcare | Financial Services |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is AbbVie Inc. bigger than The Goldman Sachs Group, Inc.?
- AbbVie Inc. has a market cap of $464.575B against $302.952B for The Goldman Sachs Group, Inc., making it 1.5 times as valuable.
- Which company earns more, ABBV or GS?
- AbbVie Inc. reported net income of $4.226B and The Goldman Sachs Group, Inc. reported $17.176B in their most recent annual periods.